TY  - JOUR
AU  - Perez, Ana Belen
AU  - Chueca, Natalia
AU  - Macias, Juan
AU  - Pineda, Juan Antonio
AU  - Salmeron, Javier
AU  - Rivero-Juarez, Antonio
AU  - Hidalgo-Tenorio, Carmen
AU  - Espinosa, Maria Dolores
AU  - Tellez, Francisco
AU  - Von-Wichmann, Miguel Angel
AU  - Omar, Mohamed
AU  - Santos, Jesus
AU  - Hernandez-Quero, Jose
AU  - Anton, Jose Joaquin
AU  - Collado, Antonio
AU  - Lozano, Ana Belen
AU  - Garcia-Deltoro, Miguel
AU  - Casado, Marta
AU  - Pascasio, Juan Manuel
AU  - Selfa, Aida
AU  - Rosales, Jose Miguel
AU  - De la Iglesia, Alberto
AU  - Arenas, Juan Ignacio
AU  - Garcia-Bujalance, Silvia
AU  - Rios, Maria Jose
AU  - Bernal, Enrique
AU  - Martinez, Onofre
AU  - Garcia-Herola, Antonio
AU  - Velez, Monica
AU  - Rincon, Pilar
AU  - Garcia, Federico
PY  - 2019
DO  - 10.1371/journal.pone.0221231
UR  - http://hdl.handle.net/10668/14460
T2  - PloS one
AB  - Treatment guidelines differ in their recommendation to determine baseline resistance associated substitutions (RAS) before starting a first-line treatment with direct-acting antivirals (DAAs). Here we analyze the efficacy of DAA treatment with...
LA  - en
PB  - Public Library of Science
KW  - Área de Gestión Sanitaria Sur de Granada
KW  - Área de Gestión Sanitaria Sur de Sevilla
KW  - Amides
KW  - Antiviral agents
KW  - Benzofurans
KW  - Carbamates
KW  - Cyclopropanes
KW  - Drug resistance, viral
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - Hepatitis C, chronic
KW  - Humans
KW  - Imidazoles
KW  - Male
KW  - Middle aged
KW  - Mutation
KW  - Quinoxalines
KW  - Ribavirin
KW  - Sofosbuvir
KW  - Spain
KW  - Sulfonamides
KW  - Sustained virologic response
KW  - Viral nonstructural proteins
TI  - Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort.
TY  - research article
VL  - 14
ER  -